ThirtyFiveBio
Abingdon
About ThirtyFiveBio
ThirtyFiveBio is a biotech company developing a gut epithelial shield for patients with colitis
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $1.4M
- Last round: Series Unknown (Apr 2025)
- Website: thirtyfivebio.com
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/thirtyfivebio-51511 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.